BioLineRx Launches 'Mobilization Matters': A Digital Resource for People with Multiple Myeloma Preparing for Stem Cell Collection

Core Insights - BioLineRx Ltd. has launched "Mobilization Matters," a digital resource aimed at supporting multiple myeloma patients preparing for stem cell collection for autologous stem cell transplants [1][2][3] Group 1: Initiative Overview - The "Mobilization Matters" platform provides patient stories, educational resources, and a discussion guide to facilitate conversations between patients and healthcare teams [1][3] - The initiative is in partnership with the HealthTree Foundation, which is conducting a survey to gather insights from patients about their experiences with stem cell collection [2][4] Group 2: Survey Details - The Mobilization Matters Stem Cell Collection Survey targets adults with multiple myeloma who have attempted stem cell collection for planned transplants [4] - The survey aims to provide insights into the emotional, physical, and daily life challenges faced by patients during the stem cell collection process, with results expected in Q1 2025 [2][5] Group 3: Industry Context - Autologous stem cell transplantation (ASCT) is the preferred first-line treatment for multiple myeloma, which is the second most common blood cancer [6] - The success of ASCT relies on adequate mobilization and collection of stem cells, but challenges are increasing due to a higher proportion of older patients and the use of more complex induction therapies [7] Group 4: Organizational Background - BioLineRx is a commercial stage biopharmaceutical company focused on developing therapies for oncology and rare diseases, with a pipeline that includes investigational drugs for sickle cell disease and pancreatic cancer [9] - The HealthTree Foundation is a nonprofit organization that provides personalized support and education to patients, leveraging patient data to advance clinical care and research [8]